Navigation Links
Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
Date:10/17/2007

CHICAGO, Oct. 17 /PRNewswire/ -- In its Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions, the Society of Gynecologic Oncologists (SGO) provides concise guidelines, usable in a primary care setting, to guide physicians as to which women with a personal or family history of breast, gynecologic or colorectal cancer may benefit from a hereditary risk assessment.

SGO's Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions offers guidance as to who may benefit from a hereditary cancer risk assessment, as well as who may receive enhanced care as a result. The statement will be published in the November issue of Gynecologic Oncology (Elsevier Science) and will be made available online at http://www.sgo.org on October 17, 2007.

Currently, as many as 1 in 10 breast, gynecologic, and colorectal cancers are caused by hereditary predispositions that genetic testing can detect -- including those for the two most commonly encountered hereditary cancer syndromes, Hereditary Breast/Ovarian Cancer Syndrome (HBOC) and Lynch/Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC). Women with HBOC have up to a 65-85% risk for breast cancer and a 39-46% risk of ovarian cancer by age 70. Women with HNPCC have a 40-60% risk for both endometrial and colorectal cancer by age 70 and an increased risk for ovarian cancer. Genetic risk assessment offers women an individualized evaluation of their likelihood of having one of these cancer predisposition syndromes and gives physicians the opportunity to provide tailored screening and prevention strategies to ultimately reduce the risk of the morbidity and mortality associated with these diseases.

"SGO's Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions provides gynecologists, gynecologic oncologists and other women's primary care providers with clear, concise, usable guidelines for identifying who may benefit from a hereditary cancer risk assessment," says Dr. Noah Kauff, Gynecologist and Cancer Geneticist at Memorial Sloan-Kettering Cancer Center in New York. "There has been a significant interest in genetic risk assessment in both the medial and lay communities, but clear-cut criteria detailing who to assess for hereditary gynecologic cancer risk have been lacking. These guidelines are an important step forward in assisting physicians' ability to make informed recommendations regarding who should undergo genetic risk assessment."

"This is all about risk-reduction," adds Dr. Andrew Berchuck, SGO's President and the Director of Duke University Medical Center's Division of Gynecologic Oncology. "The women with these hereditary cancer syndromes have a tremendously increased risk of developing breast, ovarian, colorectal or endometrial cancer. By identifying their risks early on, we can determine the best possible course of action to reduce their risks through proven screening and prevention strategies -- altering the natural history of these inherited syndromes and their effects on our patients' health."

Hereditary cancer risk assessment is a process conducted by a physician, genetic counselor or other provider with expertise in cancer genetics. It includes assessment of risk, education and counseling. Genetic testing may also be included if so desired by the patient after appropriate counseling and informed consent.

Physicians are encouraged to read an advance publication of the Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions in its entirety at http://www.sgo.org.

About SGO

The Society of Gynecologic Oncologists (SGO) is a national medical specialty society for physicians trained in the comprehensive management of women's cancers. The Society's membership is primarily comprised of gynecologic oncologists -- obstetrician/gynecologists who undertake an additional 3-4 years of intensive training in the specific study of gynecologic cancers. SGO members provide medical and surgical care to women with ovarian cancer, cervical cancer, endometrial cancer, vulvar cancer, and vaginal cancer. They are trained to in chemotherapy and radiation therapy administration, supportive care, and surgery in order to provide comprehensive care to their patients. More information on gynecologic oncology, the SGO, and its members can be found at http://www.sgo.org.

Contact: Jessica Schackmuth

(312) 235-4060


'/>"/>
SOURCE Society of Gynecologic Oncologists
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Conditions Of The HIV/AIDS Patients In The Mizo Society
2. New Zealand Researchers Call For Tobacco-Free Society
3. India to be part of global cancer society
4. Breast-Feeding In Public – Will The Society Accept It
5. Healthy People 2010 Objectives Aims To Reduce Oral Health Disparities In Society
6. Europe: Empowering Society with Knowledge
7. Rise in the Number of Premature Births Has a Bad Effect on the Society
8. Free IVF Treatment Could Prove Beneficial to the Society And Its Economy
9. Grumpy Women: Society Not Hormones At Fault
10. Demographic Change Demand a New Life-Course for Aging Society
11. American Cancer Society celebrates the Great American Smokeout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have ... sleep apnea treatment, with or without a referral. Sleep apnea is often left untreated ... daytime sleepiness, morning headaches and chronic snoring. , Dr. Braasch seeks to raise ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... gain site attention and engagement over the household brands of Top-20 pharma by ... will discuss how partnering with the right outsourcing payments provider can provide the ...
(Date:3/27/2017)... ... 27, 2017 , ... Adding to its expanding portfolio of ... and NEJM Journal Watch, announces the release of NEJM Knowledge+ Pediatrics Board ... of pediatricians from leading medical centers. The content was then reviewed and approved ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical ... Cambridge academic scientists through ... Milner Therapeutics Institute today announces Elysium Health as a partner ... investment for collaborative projects with academic researchers in ... the first major research investment outside the U.S. for the ...
(Date:3/27/2017)... 2017 Therapix Biosciences Ltd. ... in the development of cannabinoid-based drugs, today announced ... the United States of 2,000,000 ... ordinary shares of the Company, at a price ... granted the underwriters a 45-day over-allotment option to ...
(Date:3/27/2017)... VANCOUVER, British Columbia , March 27, 2017 /PRNewswire/ ... of Directors has appointed William "Bill" Dubiel as President ... Dubiel was also elected to the Board of Directors ... serve as the Executive Chairman of LightIntegra. ... become LightIntegra,s next President and Chief Executive Officer. We,ve ...
Breaking Medicine Technology: